Status: current, Defined. Date: 31-Jul 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1983621000168112 | alpha-1-proteinase inhibitor 1 g injection, 1 g vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1983631000168110 | alpha-1-proteinase inhibitor 1 g injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| alpha-1-proteinase inhibitor 1 g injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| alpha-1-proteinase inhibitor 1 g injection, vial | Is a | alpha-1-proteinase inhibitor | true | Inferred relationship | Some | ||
| alpha-1-proteinase inhibitor 1 g injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| alpha-1-proteinase inhibitor 1 g injection, vial | has unit of use | vial | true | Inferred relationship | Some | 867184897 | |
| alpha-1-proteinase inhibitor 1 g injection, vial | has intended active ingredient | alpha-1-proteinase inhibitor | true | Inferred relationship | Some | 867184896 | |
| alpha-1-proteinase inhibitor 1 g injection, vial | has Australian BoSS | alpha-1-proteinase inhibitor | true | Inferred relationship | Some | 867184896 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| alpha-1-proteinase inhibitor 1 g injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack | has MPUU | True | alpha-1-proteinase inhibitor 1 g injection, vial | Inferred relationship | Some | 1 |
| Prolastin-C (alpha-1-proteinase inhibitor 1 g) powder for injection, vial | Is a | True | alpha-1-proteinase inhibitor 1 g injection, vial | Inferred relationship | Some |
Reference Sets
Australian dialect reference set
Medicinal product unit of use reference set
FHIR